High-risk APOL1 genotype patients had a greater reduction in systolic blood pressure at 3 mo compared to low risk patients and controls. At 12 mo significant increase in urine kidney disease testing among high-risk patients. Positive lifestyle changes and increased medication use in high-risk patients. The gene discussed is APOL1; the disease is kidney disorder.